Fig. 6From: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaControlled versus uncontrolled lesions in patients progressing with measurable new lesions only. The sum of diameters of controlled lesions (responding and stable lesions combined) and the sum of diameters of uncontrolled lesions (progressing and new lesions combined) is shown relative to the sum of all lesion diameters for 15 patients in whom only measurable new lesions defined progressionBack to article page